Published in Nat Med on January 01, 2000
MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med (2008) 1.99
Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J Exp Med (2011) 1.74
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol (2007) 1.73
Assembly, structure, and function of the 26S proteasome. Trends Cell Biol (2010) 1.61
Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry (2011) 1.48
Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog (2007) 1.29
Human hepatocyte carcinogenesis (review). Int J Oncol (2013) 1.28
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. J Clin Invest (2010) 1.21
Intracellular signaling and hepatocellular carcinoma. Semin Cancer Biol (2010) 1.17
Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol (2002) 1.17
Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. Neoplasia (2011) 1.16
Elimination of C/EBPalpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice. J Clin Invest (2010) 1.15
Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res (2008) 1.13
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell (2014) 1.10
Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells. Mol Cancer Ther (2010) 1.09
Regulation of CDK4. Cell Div (2006) 1.06
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
Therapeutic targeting of cancer cell cycle using proteasome inhibitors. Cell Div (2012) 0.98
Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17. J Biol Chem (2009) 0.97
Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase. J Cell Sci (2006) 0.96
PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene (2011) 0.95
LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. Mol Cancer (2013) 0.94
Fission yeast Dss1 associates with the proteasome and is required for efficient ubiquitin-dependent proteolysis. Biochem J (2006) 0.93
Biological functions of melanoma-associated antigens. World J Gastroenterol (2004) 0.93
Assembly manual for the proteasome regulatory particle: the first draft. Biochem Soc Trans (2010) 0.91
Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. PLoS One (2007) 0.91
YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget (2015) 0.89
Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16. J Mol Biol (2007) 0.88
The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis Model Mech (2013) 0.88
The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling. Cell Res (2011) 0.88
Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines. Head Face Med (2009) 0.86
Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway. Oncogene (2015) 0.86
Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer (2011) 0.86
Resurfaced shape complementary proteins that selectively bind the oncoprotein gankyrin. ACS Chem Biol (2014) 0.86
Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis. Virology (2009) 0.84
PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression. Autophagy (2015) 0.84
Micro(RNA)managing endoplasmic reticulum stress. IUBMB Life (2013) 0.83
The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. Cancers (Basel) (2014) 0.82
The hepatic transcriptome in human liver disease. Comp Hepatol (2006) 0.82
Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance. Sci Rep (2014) 0.82
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. J Cancer Res Clin Oncol (2004) 0.81
Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma. J Exp Med (2016) 0.81
Association of gankyrin and stemness factor expression in human colorectal cancer. Dig Dis Sci (2013) 0.80
Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis (2015) 0.80
Effects of ligand binding on the mechanical properties of ankyrin repeat protein gankyrin. PLoS Comput Biol (2013) 0.79
Functional characterization of human oncoprotein gankyrin in Zebrafish. Exp Mol Med (2009) 0.78
Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol (2003) 0.78
Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma. World J Surg Oncol (2012) 0.77
The Role of Autophagy in Hepatocellular Carcinoma. Int J Mol Sci (2015) 0.77
Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors. Anticancer Res (2014) 0.76
A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor. J Biol Chem (2015) 0.76
Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model. Front Cell Neurosci (2015) 0.75
Gankyrin gene deletion followed by proteomic analysis: insight into the roles of Gankyrin in tumorigenesis and metastasis. BMC Med Genomics (2012) 0.75
Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression. Oncotarget (2016) 0.75
Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway. Oncotarget (2016) 0.75
Scratching the Surface: Resurfacing Proteins to Endow New Properties and Function. Cell Chem Biol (2016) 0.75
Purification, crystallization and preliminary X-ray diffraction analysis of the non-ATPase subunit Nas6 in complex with the ATPase subunit Rpt3 of the 26S proteasome from Saccharomyces cerevisiae. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75
APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathway. Biosci Rep (2016) 0.75
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers. Oncotarget (2016) 0.75
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. Cancer Sci (2017) 0.75
Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis. Onco Targets Ther (2016) 0.75
Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma. World J Hepatol (2016) 0.75
Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma. Cancer Sci (2017) 0.75
RNA binding protein CUGBP1 inhibits liver cancer in a phosphorylation dependent manner. Mol Cell Biol (2017) 0.75
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A (2001) 6.78
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun (1995) 6.55
Carcinoid tumors. N Engl J Med (1999) 6.44
Gastric carcinoma. N Engl J Med (1995) 5.77
Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem (2000) 5.75
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71
Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature (1994) 4.20
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci (2001) 4.02
Geoelectric potential changes: possible precursors to earthquakes in Japan. Proc Natl Acad Sci U S A (2000) 3.93
Transport of live animals for slaughter. Vet Rec (1991) 3.83
Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol (1996) 3.72
Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. J Immunol Methods (1979) 3.33
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Electric and magnetic phenomena observed before the volcano-seismic activity in 2000 in the Izu Island Region, Japan. Proc Natl Acad Sci U S A (2002) 3.18
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04
Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun (1999) 3.03
Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int (2001) 2.90
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69
Portal vein anomaly associated with deviation of the ligamentum teres to the right and malposition of the gallbladder. Radiology (1998) 2.62
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res (1998) 2.56
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer (1998) 2.48
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol (1991) 2.46
The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol (1996) 2.43
Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci U S A (1995) 2.42
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol (2001) 2.40
Primary central nervous system lymphoma. Ann Intern Med (1993) 2.36
Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood (1991) 2.35
A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol (1993) 2.26
Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24
Carcinoma of the anal canal. N Engl J Med (2000) 2.22
Sugar-sweetened beverage and diet soda consumption and the 7-year risk for type 2 diabetes mellitus in middle-aged Japanese men. Eur J Nutr (2013) 2.20
Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice. Lab Anim (1985) 2.12
Localization of myosin II A and B isoforms in cultured neurons. J Cell Sci (1995) 2.11
Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol Med (2001) 2.10
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells (2000) 2.05
Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol (1994) 2.05
Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. J Immunol (1985) 2.03
A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis (2011) 2.02
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. Nature (1984) 1.99
Chemoprevention of colorectal cancer. N Engl J Med (2000) 1.98
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.97
Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol Cell Biol (1995) 1.97
Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J Exp Med (1987) 1.96
A glycine-rich RNA-binding protein mediating cold-inducible suppression of mammalian cell growth. J Cell Biol (1997) 1.95
Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol (1999) 1.95
Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells (2001) 1.95
Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens (1998) 1.93
Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide. Ann Intern Med (2000) 1.90
A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax (2007) 1.89
Laparoscopic side-to-side esophagogastrostomy using a linear stapler after proximal gastrectomy. Gastric Cancer (2001) 1.89
Ultrasound instruments as possible vectors of staphylococcal infection. J Hosp Infect (1998) 1.85
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer (1998) 1.82
Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells. J Immunol (1983) 1.80
Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996. Lancet (1996) 1.75
Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol (2000) 1.73
G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature (2000) 1.68
Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest (1996) 1.67
Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J Neurosci (1996) 1.67
Organisational change: the key to quality improvement. Qual Health Care (1998) 1.66
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology (1996) 1.65
Pancreatic enzyme supplement dosage in cystic fibrosis. Lancet (1991) 1.64
Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). J Immunol (1985) 1.64
Purification and properties of nitroalkane oxidase from Fusarium oxysporum. J Bacteriol (1978) 1.62
Influences on clinical practice: the case of glue ear. Qual Health Care (1999) 1.62
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol (2002) 1.62
Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes (1983) 1.62
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology (2000) 1.61
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J (2000) 1.58
Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer (1998) 1.57
Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry (1989) 1.57
Radiographic progression of hospital referred osteoarthritis of the hip. Ann Rheum Dis (1993) 1.57
A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett (1988) 1.55
Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology (1997) 1.55
Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol (1989) 1.54
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol (1989) 1.53
Cavitary lung cancer with an aspergilloma-like shadow. Lung Cancer (1999) 1.53
Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation. J Immunol (1983) 1.53
Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 1.52
Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res (1995) 1.51
Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol (1990) 1.51
B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest (1984) 1.51
Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities. J Immunol (1982) 1.51
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res (2001) 1.51
Transection of the pituitary stalk: development of an ectopic posterior lobe assessed with MR imaging. Radiology (1987) 1.50
Isolation of B bronchiseptica from kittens with pneumonia in a breeding cattery. Vet Rec (1991) 1.50
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res (1986) 1.50
Action potential-dependent regulation of gene expression: temporal specificity in ca2+, cAMP-responsive element binding proteins, and mitogen-activated protein kinase signaling. J Neurosci (1997) 1.49
pp60c-src activation in lung adenocarcinoma. Eur J Cancer (2003) 1.49
Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B, and K cell traffic in the peripheral blood. J Immunol (1981) 1.49
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol (2001) 1.48
Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res (1999) 1.48